Thrombotic and bleeding complications during antithrombotic treatment: the need for new therapeutic targets

Eur Heart J. 2023 May 21;44(20):1767-1770. doi: 10.1093/eurheartj/ehad285.

Author

Filippo Crea^{1

2}

Affiliations

¹ Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
² Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.

PMID: 37210634
DOI: 10.1093/eurheartj/ehad285

No abstract available

MeSH terms

Fibrinolytic Agents* / adverse effects
Humans
Risk Factors
Thrombosis* / drug therapy
Thrombosis* / etiology

Substances

Fibrinolytic Agents